Analysis of combined modality treatment results in patients with advanced ovarian cancer
Автор: Kairbaeva M.Zh.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Опыт работы онкологических учреждений
Статья в выпуске: 4 (34), 2009 года.
Бесплатный доступ
Current study based on retrospective analyses of treatment of 271 advanced ovarian cancer patients. FIGO stage III disease was found in 179 patients and stage IV diagnosed in 92 patients. Most common histology type was serous - 84 %. Combination of surgery and chemotherapy took place in 92,2 % of patients. At first step of the treatment 73 % of patients underwent surgery. Neoadjuvant chemotherapy as first treatment had been used in 24,8 % of patients. Most commonly used treatment was started from chemotherapy with optimal interval and secondary cytoreductive surgery. The best survival indexes were achieved in FIGO stage III ovarian cancer patients.
Advanced ovarian cancer, combined modality treatment
Короткий адрес: https://sciup.org/14055174
IDR: 14055174